Brevan Howard Capital Management LP

Position in AMPH — Amphastar Pharmaceuticals, Inc.

CIK 1512857 ST. HELIER, Y9

Back to AMPH Full portfolio

Position in AMPH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$690,176

+$462,658 QoQ

Shares Held

34,201

+194.5% QoQ

Ownership

0.080%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#76

of 209 holders

Holding Since

Mar 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMPH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Brevan Howard Capital Management LP holds $20,713,489 across 26 Drug Manufacturers - Specialty & Generic names. AMPH ranks #11 (3.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	231,624	$3,678,189
2	UTHR	UNITED THERAPEUTICS Corp	4,174	$2,261,598
3	ZTS	Zoetis Inc.	26,423	$1,898,755
4	LQDA	Liquidia Corp	20,664	$1,647,540
5	LNTH	Lantheus Holdings, Inc.	14,589	$1,618,503
6	AMRX	Amneal Pharmaceuticals, Inc.	85,545	$1,480,783
7	HIMS	Hims & Hers Health, Inc.	38,148	$1,322,591
8	BCRX	Biocryst Pharmaceuticals Inc	96,574	$965,740

All Filings in AMPH

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$690,176	34,201	+194.5%	Shares	Defined	2026-08-14
2026-03-31	$227,518	11,614	-43.2%	Shares	Defined	2026-05-15
2025-12-31	$548,052	20,465	+51.7%	Shares	Defined	2026-02-17
2025-09-30	$359,481	13,489	-72.4%	Shares	Defined	2025-11-14
2025-06-30	$1,123,203	48,920	+469.8%	Shares	Defined	2025-08-14
2025-03-31	$248,879	8,585	+24.3%	Shares	Defined	2025-05-15
2024-12-31	$256,382	6,905	+25.2%	Shares	Defined	2025-02-14
2024-03-31	$242,119	5,514	—	Shares	Defined	2024-05-15
No filing history on record for this holder in this stock.